Literature DB >> 30914143

Triglycerides and cardiovascular risk: Apolipoprotein B holds the key.

Jane Stock1.   

Abstract

Entities:  

Keywords:  Apoliprotein B; Cardiovascular; Ference and colleagues study; Low-density lipoprotein; Triglycerides

Mesh：

Substances：

Year:  2019        PMID： 30914143     DOI： 10.1016/j.atherosclerosis.2019.03.004

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN： 0021-9150            Impact factor:   5.162


× No keyword cloud information.
  6 in total

Review 1.  Different physiological mechanisms underlie an adverse cardiovascular disease risk profile in men and women.

Authors:  Alan Fappi; Bettina Mittendorfer
Journal:  Proc Nutr Soc       Date:  2019-07-25       Impact factor: 6.297

Review 2.  Potential of Phage Display Antibody Technology for Cardiovascular Disease Immunotherapy.

Authors:  Soo Ghee Yeoh; Jia Siang Sum; Jing Yi Lai; W Y Haniff W Isa; Theam Soon Lim
Journal:  J Cardiovasc Transl Res       Date:  2021-08-31       Impact factor: 3.216

3.  High Plasma Concentration of Apolipoprotein C-III Confers an Increased Risk of Cerebral Ischemic Events on Cardiovascular Patients Anticoagulated With Warfarin.

Authors:  Oliviero Olivieri; Gianni Turcato; Manuel Cappellari; Filippo Stefanoni; Nicola Osti; Francesca Pizzolo; Simonetta Friso; Antonella Bassi; Annalisa Castagna; Nicola Martinelli
Journal:  Front Cardiovasc Med       Date:  2022-02-04

Review 4.  Triglyceride-Rich Lipoproteins and Their Remnants as Silent Promoters of Atherosclerotic Cardiovascular Disease and Other Metabolic Disorders: A Review.

Authors:  Radu Sascău; Alexandra Clement; Rodica Radu; Cristina Prisacariu; Cristian Stătescu
Journal:  Nutrients       Date:  2021-05-22       Impact factor: 5.717

5.  Apolipoprotein B and renal function: across-sectional study from the China health and nutrition survey.

Authors:  Wenbo Zhao; Junqing Li; Xiaohao Zhang; Xiaomei Zhou; Junyi Xu; Xun Liu; Zifeng Liu
Journal:  Lipids Health Dis       Date:  2020-05-27       Impact factor: 3.876

6.  Increased serum concentration of apolipoprotein B is associated with an increased risk of reaching renal replacement therapy in patients with diabetic kidney disease.

Authors:  Wen-Bo Zhao; Lin Zhu; Tohty Rahman
Journal:  Ren Fail       Date:  2020-11       Impact factor: 2.606
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.